Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants

NCT05989035
completednot_applicable

Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism

NCT04675255
completednot_applicable

Brown Adipose Tissue Activity and Energy Metabolism in Cachexia

NCT02500004

Clinical Trials (3)

Showing 3 of 3 trials
NCT05989035Not Applicable

Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants

Completed
NCT04675255Not Applicable

Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism

Completed
NCT02500004Not Applicable

Brown Adipose Tissue Activity and Energy Metabolism in Cachexia

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3